ERN1 and Miyoshi myopathy: Moreover, when using the IRE1α inhibitor to inactivate this signaling pathway, we discovered that the reduced Xbp1s formation strikingly impaired bortezomib-induced mineralization and significantly reduced the expression of osteogenic differentiation markers in MM-MSCs (Supplemental Figure 4).